A Study of Olaratumab (LY3012207), Doxorubicin, and Ifosfamide in Participants With Advanced or Metastatic Soft Tissue Sarcoma
Clinical trial NCT03283696 · COMPLETED
Trial details
- NCT number
- NCT03283696
- Sponsor
- Eli Lilly and Company
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2017-10-18
- Primary completion
- 2019-04-29
- Enrollment
- 24
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.